Christian Dong, PhD, MBA, is an experienced scientific advisor specializing in pharmacoeconomics with a strong grasp of payers' decision-making processes and the Canadian reimbursement landscape. Currently serving as a Senior Manager in Access for Rare Disease/Gene Therapy at Pfizer, they leverage their strategic thinking and project management skills to drive impactful solutions. Christian previously held the position of Scientific Advisor at INESSS from 2016 to 2021 and has advanced education credentials, including a PhD in Neuroscience and an MBA from HEC Montréal.
This person is not in any teams
This person is not in any offices